Mr. Peter Deyoung has been with Piramal Pharma Ltd since March 4, 2020, and has recently been re-appointed as Executive Director for a further term of three years starting October 6, 2023.
He holds a Bachelor's Degree in Science (Engineering) from Princeton University, USA, graduating summa cum laude.
His extensive experience and expertise in healthcare and pharmaceuticals have been instrumental in steering the strategy and driving the growth of Piramal Global Pharma, with significant milestones achieved during his tenure.
The Board of Directors recognized his contributions and approved the terms of his remuneration in line with the Company's Remuneration Policy.
Peter Deyoung is currently a Executive Director & CEO in Piramal Pharma Ltd (as of Mar 2024).
Peter Deyoung is serving the company - Piramal Pharma Ltd at this position since 2023 for the last 3+ years.
Peter Deyoung was Executive Director & CEO of Piramal Pharma Ltd for 2 years from 2023 to 2024.
FAQ's related Peter Deyoung
Who is Peter Deyoung
Mr. Peter Deyoung has been with Piramal Pharma Ltd since March 4, 2020, and has recently been re-appointed as Executive Director for a further term of three years starting October 6, 2023. He holds a Bachelor's Degree in Science (Engineering) from Princeton University, USA, graduating summa cum laude. His extensive experience and expertise in healthcare and pharmaceuticals have been instrumental in steering the strategy and driving the growth of Piramal Global Pharma, with significant milestones achieved during his tenure. The Board of Directors recognized his contributions and approved the terms of his remuneration in line with the Company's Remuneration Policy.
Which companies does Peter Deyoung serve as a board member for?
Peter Deyoung serves as a board member for: Piramal Pharma Ltd
What positions has Peter Deyoung held in his/her career?
Throughout their career, Peter Deyoung has held key positions such as Executive Director & CEO, contributing to the growth and success of each company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.